[HTML][HTML] Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future
R Alzeibak, TA Mishchenko, NY Shilyagina… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
The past decade has witnessed major breakthroughs in cancer immunotherapy. This
development has been largely motivated by cancer cell evasion of immunological control …
development has been largely motivated by cancer cell evasion of immunological control …
Ferroptosis and photodynamic therapy synergism: enhancing anticancer treatment
TA Mishchenko, IV Balalaeva, MV Vedunova… - Trends in cancer, 2021 - cell.com
Photodynamic therapy (PDT) is widely used in cancer treatment; however, several
challenges compromise its efficiency. We propose a synergistic action between PDT and …
challenges compromise its efficiency. We propose a synergistic action between PDT and …
[HTML][HTML] Targeted delivery to tumors: multidirectional strategies to improve treatment efficiency
OM Kutova, EL Guryev, EA Sokolova, R Alzeibak… - Cancers, 2019 - mdpi.com
Malignant tumors are characterized by structural and molecular peculiarities providing a
possibility to directionally deliver antitumor drugs with minimal impact on healthy tissues and …
possibility to directionally deliver antitumor drugs with minimal impact on healthy tissues and …
[HTML][HTML] Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
VD Turubanova, IV Balalaeva, TA Mishchenko… - … for immunotherapy of …, 2019 - Springer
Background Anti-cancer therapy is more successful when it can also induce an
immunogenic form of cancer cell death (ICD). Therefore, when developing new treatment …
immunogenic form of cancer cell death (ICD). Therefore, when developing new treatment …
Radioactive (90Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer
EL Guryev, NO Volodina… - Proceedings of the …, 2018 - National Acad Sciences
We report combined therapy using upconversion nanoparticles (UCNP) coupled to two
therapeutic agents: beta-emitting radionuclide yttrium-90 (90Y) fractionally substituting …
therapeutic agents: beta-emitting radionuclide yttrium-90 (90Y) fractionally substituting …
[HTML][HTML] Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death
VD Turubanova, TA Mishchenko, IV Balalaeva… - Scientific Reports, 2021 - nature.com
The immunogenicity of dying cancer cells determines the efficacy of anti-cancer therapy.
Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is …
Photodynamic therapy (PDT) can induce immunogenic cell death (ICD), which is …
Novel regular polyimide‐graft‐(polymethacrylic acid) brushes: Synthesis and possible applications as nanocontainers of cyanoporphyrazine agents for photodynamic …
AV Yakimansky, TK Meleshko… - Journal of Polymer …, 2013 - Wiley Online Library
An approach to the synthesis of new regular graft‐copolymers polyimide (PI)‐graft‐
polymethacrylic acid is elaborated, including (1) synthesis of multicenter PI …
polymethacrylic acid is elaborated, including (1) synthesis of multicenter PI …
Water-soluble chlorin/arylaminoquinazoline conjugate for photodynamic and targeted therapy
VF Otvagin, NS Kuzmina, LV Krylova… - Journal of Medicinal …, 2019 - ACS Publications
A new water-soluble conjugate, consisting of a chlorin-e 6 photosensitizer part, a 4-
arylaminoquinazoline moiety with affinity to epidermal growth factor receptors, and a …
arylaminoquinazoline moiety with affinity to epidermal growth factor receptors, and a …
Synthesis and biological evaluation of new water-soluble photoactive chlorin conjugate for targeted delivery
VF Otvagin, AV Nyuchev, NS Kuzmina… - European Journal of …, 2018 - Elsevier
A new water-soluble conjugate, consisting of a chlorin-based photosensitizing part, and a 4-
arylaminoquinazoline moiety with high potential affinity to an epidermal growth factor …
arylaminoquinazoline moiety with high potential affinity to an epidermal growth factor …
[HTML][HTML] Photobiological properties of phthalocyanine photosensitizers Photosens, Holosens and Phthalosens: A comparative in vitro analysis
AA Brilkina, LV Dubasova, EA Sergeeva… - … of Photochemistry and …, 2019 - Elsevier
Photobiological properties of phthalocyanine photosensitizers, namely, clinically approved
Photosens and new compounds Holosens and Phthalosens were analyzed on transitional …
Photosens and new compounds Holosens and Phthalosens were analyzed on transitional …